“This licensing agreement underscores our commitment to make it easier for customers to do business with Solvay and our partners,” said Jeff Hrivnak
READING, Pa. (PRWEB) October 18, 2019
Stock shapes produced from Zeniva® PEEK, high-performance biocompatible polymers, are used primarily for orthopedic, cardiac and neurological implantable devices . Performance benefits of Zeniva® PEEK shapes include biostability, high strength and stiffness, fatigue resistance and exceptional dimensional stability. These shapes are ideal for the close tolerance machining of finished components, and for prototypes used in injection molding applications. Additionally, Zeniva® PEEK stock shapes have numerous advantages over metals, such as a reduction in stress shielding, no heavy metal allergy or ion erosion, and radiolucent properties which allow x-ray and CT scanning procedures to occur without interference.
“We are very excited to further our implantable shapes strategy with the addition of Zeniva® PEEK, which complements our existing portfolio of UHMW implantable products. In conjunction with MediTECH’S unique “Near Net” manufacturing technology, we can provide customers with productivity improvements and a simplified supply chain” says Eric Tech, Global Market Manager for the Medical industry at Mitsubishi Chemical Advanced Materials. Matt Donahey, MediTECH’S® Global Director, states that “As a global leader whose manufacturing facilities are certified under ISO 13485, MediTECH® can also provide customers with deep expertise in regulatory, compliance, and supply chain management. For more than 30 years, Mitsubishi Chemical Advanced Materials' MediTECH® Division has supplied leading orthopedic implantable device manufacturers with premium implantable-grade UHMW-PE under the Chirulen® and Extrulen® brand names.”
Jeff Hrivnak, Global Business Manager for Healthcare at Solvay’s Specialty Polymers global business unit adds, “This licensing agreement underscores our commitment to make it easier for customers to do business with Solvay and our partners. By reassigning fulfillment activities to MediTECH®, our customers will also benefit from their deep expertise in regulatory requirements, as well as polymer shape technologies.”
Both companies- MediTECH® and Solvay- are excited to enter into this new agreement that stems from a long history and partnership. Mitsubishi Chemical Advanced Materials has manufactured Solvay’s Zeniva® PEEK shapes since the material’s inception 12 years ago. Zeniva® PEEK resin and stock shapes comply with ISO 13485 manufacturing standards and meet current Good Manufacturing Practices (GMP). Based on rigorous biocompatibility testing, these products demonstrate no evidence of cytotoxicity, sensitization, irritation, or acute systemic toxicity as defined by ISO 10993. These products can be sterilized using all conventional methods, including gamma radiation, ethylene oxide, and steam.
About Mitsubishi Chemical Advanced Materials
With more than 80 years of experience, 30 branch offices in 20 countries, and a team of technical service experts, engineers, and application development managers, Mitsubishi Chemical Advanced Materials** is the global leader for researching, developing, and manufacturing high-performance engineered polymer materials. Our products make the world a safer place by providing solutions across all industries- food processing and packaging, aerospace and defense, semiconductor, oil and gas, medical and life sciences, renewable energy, construction and heavy equipment, and electronics.
Registered trademarks of Mitsubishi Chemical Advanced Materials include: Acetron®, CleanStat®, Duratron®, Ertalyte®, Ertalene®, Ertalon®, Fluorosint®, Ketron®, Nylatron®, Proteus®, Sanalite®, Semitron®, Techtron®, and TIVAR®. Learn more at http://www.mcam.com and on LinkedIn at https://www.linkedin.com/company/mcamconnect/
**Mitsubishi Chemical Advanced Materials, formerly Quadrant EPP, was officially named on April 1st, 2019. The Quadrant Group was established in 2001 and acquired by Mitsubishi Chemical Corporation in 2013.
For more than 30 years, Mitsubishi Chemical Advanced Materials' MediTECH® Division has supplied leading orthopedic implant manufacturers with premium implantable grade UHMW-PE under the Chirulen® and Extrulen® brand names. Due to their superior physical and mechanical properties, cleanliness and consistency, Chirulen® and Extrulen® have become the materials of choice for helping restore a higher quality of life to millions of patients worldwide.
Solvay is an advanced materials and specialty chemicals company, committed to developing chemistry that addresses key societal challenges. Solvay innovates and partners with customers worldwide in many diverse end markets. Its products are used in planes, cars, batteries, smart and medical devices, as well as in mineral and oil and gas extraction, enhancing efficiency and sustainability. Its light weighting materials promote cleaner mobility, its formulations optimize the use of resources and its performance chemicals improve air and water quality. Solvay is headquartered in Brussels with around 24,500 employees in 61 countries. Net sales were €10.3 billion in 2018, with 90% from activities where Solvay ranks among the world's top 3 leaders, resulting in an EBITDA margin of 22%. Solvay SA (SOLB.BE) is listed on Euronext Brussels and Paris Bloomberg: SOLB.BB - Reuters: SOLB.BR), and in the United States its shares (SOLVY) are traded through a level-1 ADR program. Financial figures take into account the planned divestment of Polyamides.
Solvay Specialty Polymers manufactures over 1500 products across 35 brands of high-performance polymers – fluoropolymers, fluoroelastomers, fluorinated fluids, semi-aromatic polyamides, sulfone polymers, ultra-high performance aromatic polymers, and high barrier polymers – for use in Aerospace, Alternative Energy, Automotive, Healthcare, Membranes, Oil and Gas, Packaging, Plumbing, Semiconductors, Wire & Cable, and other industries. Learn more at http://www.solvayspecialtypolymers.com.
For additional questions and media inquiries, please contact Kathena Siegel at Mitsubishi Chemical Advanced Materials.